Insmed, Inc. (NASDAQ:INSM)

CAPS Rating: 2 out of 5

Insmed Incorporated, a biopharmaceutical company, is focused on developing and commercializing novel, targeted inhalation therapies.

Recs

1
Player Avatar obiwankenobe1250 (91.31) Submitted: 3/3/2007 8:51:47 AM : Underperform Start Price: $15.60 INSM Score: +61.17

Voraciously consuming an inordinate amount of cash relative to its revenues. Long term prospects had better pan out, because the near term looks pretty dismal. And besides, downwithpumpers provided the tip.

Featured Broker Partners


Advertisement